At a glance
- Originator Scios
- Class Anti-inflammatories; Antirheumatics; Branched-chain amino acids; Fluorenes; Small molecules
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Allergic contact dermatitis; Atherosclerosis; Reperfusion injury; Ulcerative colitis
- Discontinued Rheumatoid arthritis
Most Recent Events
- 14 May 2001 Discontinued-Preclinical for Rheumatoid arthritis in USA (Unknown route)
- 13 Jul 1999 No-Development-Reported for Allergic contact dermatitis in USA (Unknown route)
- 13 Jul 1999 No-Development-Reported for Atherosclerosis in USA (Unknown route)